Fluphenazine Hydrochloride Tablet, Film Coated
Product Images NDC 0832-6004

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fluphenazine Hydrochloride (NDC 0832-6004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories,llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fluphenazine 01)

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Principal Display Panel (1 mg Tablet Bottle Label)
This is a drug description for Fluphenazine which mentions the quantity of its main component as 1 mg per tablet, and the usual dosage information is available on the packaging. The tablets are required to be stored at room temperature below 25°C, with permissible excursions between 15°C and 30°C. Additionally, the tablets must be protected from light and excessive heat. The manufacturer suggests dispensing the drug in a high-resistant container as defined by USP. These tablets are to be kept out of the range of children. The manufacturer is UpsherSmith Laboratories, LLC, with a neutral code of DRUGS/APIDI 2006. The information is updated in 2022.*
FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
Each tablet contains Fluphenazine USP 25 mg. The usual dosage should be determined by a physician based on the patient's condition. The tablets should be stored at controlled room temperature and kept out of reach of children. The medication should be dispensed in a light-resistant container as defined by the USP. Manufactured by Upsher-Smith Laboratories, LLC in India. This is a prescription drug and should only be taken under the supervision of a doctor.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
This is a prescription medication manufactured for Upsher-Smith Laboratories LLC in Maple Grove, MN. The packaging contains 100 tablets and provides information about the usual dosage, storage conditions, and pharmacist instructions. The medication contains flu hydrochloride and comes in a light-resistant container with a child-resistant closure. The neutral code for this drug is DRUGS/APID1/2008.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Each tablet contains 10mg of Fluphenazine hydrochloride USP. The usual dosage information can be found in the package insert for prescribing. Store at a temperature between 20 to 25°C (66° 1077 excursions permitd o 15°to 30°C (59° 0 86°F)). Protect from excessive heat and light, and keep out of the reach of children. Dispense in a tight, light-resistant container as defined by the USP with a child-resistant closure. Manufactured by Upsher-Smith Laboratories LLC in India. The product has the Neura Code DRUGS/APIDI 2006. Revision date of the label is August 2022.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.